UMR145, Institut de Recherche pour le Développement (IRD) and Université Montpellier 1, Montpellier, France.
Retrovirology. 2011 Jan 13;8:4. doi: 10.1186/1742-4690-8-4.
Data on the evolution of natural SIV infection in chimpanzees (SIVcpz) and on the impact of SIV on local ape populations are only available for Eastern African chimpanzee subspecies (Pan troglodytes schweinfurthii), and no data exist for Central chimpanzees (Pan troglodytes troglodytes), the natural reservoir of the ancestors of HIV-1 in humans. Here, we report a case of naturally-acquired SIVcpz infection in a P.t.troglodytes chimpanzee with clinical and biological data and analysis of viral evolution over the course of infection.
A male chimpanzee (Cam155), 1.5 years, was seized in southern Cameroon in November 2003 and screened SIV positive during quarantine. Clinical follow-up and biological analyses have been performed for 7 years and showed a significant decline of CD4 counts (1,380 cells/mm³ in 2004 vs 287 in 2009), a severe thrombocytopenia (130,000 cells/mm³ in 2004 vs 5,000 cells/mm³ in 2009), a weight loss of 21.8% from August 2009 to January 2010 (16 to 12.5 kg) and frequent periods of infections with diverse pathogens.DNA from PBMC, leftover from clinical follow-up samples collected in 2004 and 2009, was used to amplify overlapping fragments and sequence two full-length SIVcpzPtt-Cam155 genomes. SIVcpzPtt-Cam155 was phylogenetically related to other SIVcpzPtt from Cameroon (SIVcpzPtt-Cam13) and Gabon (SIVcpzPtt-Gab1). Ten molecular clones 5 years apart, spanning the V1V4 gp120 env region (1,100 bp), were obtained. Analyses of the env region showed positive selection (dN-dS >0), intra-host length variation and extensive amino acid diversity between clones, greater in 2009. Over 5 years, N-glycosylation site frequency significantly increased (p < 0.0001).
Here, we describe for the first time the clinical history and viral evolution of a naturally SIV infected P.t.troglodytes chimpanzee. The findings show an increasing viral diversity over time and suggest clinical progression to an AIDS-like disease, showing that SIVcpz can be pathogenic in its host, as previously described in P.t.schweinfurthii. Although studying the impact of SIV infection in wild apes is difficult, efforts should be made to better characterize the pathogenicity of the ancestors of HIV-1 in their natural host and to find out whether SIV infection also plays a role in ape population decline.
关于在黑猩猩(SIVcpz)中自然发生的 SIV 感染的演变,以及 SIV 对当地猿类种群的影响的数据,仅可用于东非黑猩猩亚种(Pan troglodytes schweinfurthii),而对于 HIV-1 的祖先的天然宿主中非黑猩猩(Pan troglodytes troglodytes),尚无数据。在这里,我们报道了一例自然获得性 SIVcpz 感染的病例,该病例来自 P.t.troglodytes 黑猩猩,具有临床和生物学数据,并对感染过程中的病毒进化进行了分析。
一只雄性黑猩猩(Cam155),1.5 岁,于 2003 年 11 月在喀麦隆南部被捕获,并在检疫期间筛查出 SIV 阳性。进行了 7 年的临床随访和生物学分析,结果显示 CD4 计数显著下降(2004 年为 1380 个/立方毫米,2009 年为 287 个/立方毫米),严重的血小板减少症(2004 年为 130,000 个/立方毫米,2009 年为 5,000 个/立方毫米),体重减轻 21.8%(从 2009 年 8 月至 2010 年 1 月,体重从 16 公斤降至 12.5 公斤),并且经常受到多种病原体的感染。来自 2004 年和 2009 年临床随访样本的 PBMC DNA 用于扩增重叠片段,并对两个全长 SIVcpzPtt-Cam155 基因组进行测序。SIVcpzPtt-Cam155 在系统发育上与来自喀麦隆(SIVcpzPtt-Cam13)和加蓬(SIVcpzPtt-Gab1)的其他 SIVcpzPtt 相关。获得了 10 个相隔 5 年的分子克隆,跨越 V1V4 gp120 env 区(1,100 bp)。对 env 区的分析表明存在正选择(dN-dS>0),宿主内长度变异和克隆之间广泛的氨基酸多样性,2009 年的差异更大。超过 5 年,N-糖基化位点频率显著增加(p <0.0001)。
在这里,我们首次描述了自然感染 SIV 的 P.t.troglodytes 黑猩猩的临床病史和病毒演变。研究结果表明,病毒多样性随时间而增加,并表明临床进展为艾滋病样疾病,这表明 SIVcpz 可能像以前在 P.t.schweinfurthii 中那样在其宿主中具有致病性。尽管研究野生猿类中的 SIV 感染具有挑战性,但应努力更好地描述 HIV-1 祖先在其自然宿主中的致病性,并确定 SIV 感染是否也在猿类种群减少中发挥作用。